In this webinar, Dr. Anne-Laure Cattin from the Cancer Dynamics Laboratory at The Francis Crick Institute in London, will share her research on kidney cancer, focusing on the integration of multiplexed immunofluorescence using a 66-plex antibody panel alongside single-cell spatial transcriptomics on the same tumour tissue sections. She will explore how different components of the tumour microenvironment (TME) in patients with advanced clear cell renal cell carcinoma (ccRCC) are linked to their responses to immunotherapy.
Explore our ready-to-use Mouse Immuno-Oncology PhenoCode Discovery Panel featuring 24 key immune cell and tumor biomarkers for interrogation of the TME.
Discover our off-the-shelf Human IO60 PhenoCode Discovery Panel that includes 60 key markers across immune cell types, checkpoints, and tumor-specific pathways for comprehensive spatial phenotyping of the human TME.
See how the Akoya PhenoCycler-Fusion 2.0 solution is helping provide insights into complex biological systems and gain a better understanding of cellular microenvironments.
Related Posts
Accelerate Building Custom Spatial Proteomic Panels for New Biological Insights
Ultrasensitive Neuroimmune Biomarker Measurement for Translational Research and Therapeutic Development
Underdiagnosis of Alzheimer’s disease pathology in patients with cardiovascular disease
Decoding Neurodegeneration: High-plex Spatial Proteomics Reveal Distinct Cell Phenotypes and Pathological Signatures in Parkinson’s and Alzheimer’s Disease
In this webinar, Dr. Birgitt Schuele, Associate Professor (Research) of Pathology at Stanford University, showcases how ultrahigh-plex spatial proteomics is being used to uncover distinct cell phenotypes and pathological signatures…
Understanding the Brain: Advancing Neurodegeneration Research with Ultrahigh-Plex Spatial Proteomics
In this webinar, learn how ultrahigh-plex spatial phenotyping has been applied to neurodegenerative disease research.
p-Tau 205 and p-Tau 212: Emerging Biomarkers for Alzheimer’s Disease Research
Spatial Awareness: AI-powered Profiling of Trillions of Immune Cell Distribution Data Points Reveals Key Predictors of Cancer Recurrence Risk
This webinar highlights a groundbreaking study recently published as a Nature cover story (April 2025). Dr. Joe Yeong will describe how a pre-designed analytical framework—driven by well-defined clinical and scientific…
Tertiary Lymphoid Structures in Cancer Immunotherapy: Insights and Perspectives
Tertiary lymphoid structures (TLS) have emerged as critical components of the tumor microenvironment, influencing immune responses and clinical outcomes in cancer.